Akso Health GroupAHG +10.14%36 Current Ratio is 1.53 as of Sep. 2025, which is 58% below its 10-year median of 3.65. GuruFocus rates AHG with a GF Score™ of 36/100 and a GF Value™ of $0.47 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 120 Medical Distribution companies, Akso Health Group ranks better than 58.33% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Akso Health Group's current ratio for the quarter that ended in Sep. 2025 was 1.53.
Akso Health Group has a current ratio of 1.53. It generally indicates good short-term financial strength.
The historical rank and industry rank for Akso Health Group's Current Ratio or its related term are showing as below:
AHG'
s Current Ratio Range Over the Past 10 Years
Min: 1.15 Med: 3.65 Max: 39.52
Current: 1.53
During the past 11 years, Akso Health Group's highest Current Ratio was 39.52. The lowest was 1.15. And the median was 3.65.
AHG's Current Ratio is ranked better than 58.33% of 120
companies
in the Medical Distribution industry
Industry Median: 1.4
vs AHG: 1.53
Akso Health Group (NAS:AHG) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Akso Health Group Current Ratio Related Terms
Akso Health Group Current Ratio Historical Data
* Premium members only.
The historical data trend for Akso Health Group's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Akso Health Group's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akso Health Group Current Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Akso Health Group's Current Ratio distribution charts can be found below:
* The bar in red indicates where Akso Health Group's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akso Health Group (AHG) has a Current Ratio of 1.53 as of Sep. 2025. This is 58% below median its historical median of 3.65. Over the past decade, Akso Health Group's Current Ratio has ranged from 1.15 to 39.52. According to the industry distribution chart, Akso Health Group ranks #50 out of 120 companies in the Medical Distribution industry, placing it in the top 41.7%.
Is Akso Health Group's Current Ratio too high?
Akso Health Group's current Current Ratio of 1.53 is 58% below median its 10-year median of 3.65. Over the past 10 years, this metric has ranged from a low of 1.15 to a high of 39.52. The Medical Distribution industry median Current Ratio is 1.40. Akso Health Group's value of 1.53 is 9.3% above this industry median. Based on the distribution chart, Akso Health Group ranks #50 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Akso Health Group has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Akso Health Group's Current Ratio compare to ACH and EDAP?
According to the Medical Distribution industry distribution chart, Akso Health Group ranks #50 out of 120 companies for Current Ratio. This puts Akso Health Group in the upper half of its industry. The industry median Current Ratio is 1.40. Akso Health Group's value of 1.53 is 9.3% above this benchmark. Historically, Akso Health Group's own Current Ratio has ranged from 1.15 to 39.52 over the past decade. While the company's 10-year median is 3.65 vs. the industry median of 1.40, Akso Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Distribution company?
The median Current Ratio among Medical Distribution companies is 1.40, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Akso Health Group's current Current Ratio of 1.53 is 9.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median Current Ratio is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akso Health Group's current Current Ratio is 1.53, which is 58% below median its own 10-year median of 3.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akso Health Group stock overvalued right now?
Based on GuruFocus' analysis, Akso Health Group (AHG) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.47, compared to a current price of $1.52 — trading 223.4% above its estimated fair value. The current Current Ratio is 1.53, which is 58% below median its 10-year median of 3.65 and 9.3% above the Medical Distribution industry median of 1.40. Akso Health Group's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Akso Health Group (AHG), the current Current Ratio is 1.53 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Akso Health Group (AHG) Overvalued in 2026?
Based on GuruFocus' analysis, Akso Health Group stock appears to be overvalued.
The current stock price of $1.52 is trading 223.4% above its estimated GF Value™ of $0.47.
GuruFocus considers Akso Health Group to be Significantly Overvalued.
Key valuation signals for AHG:
Current Ratio: 1.53 (58% below median its 10-year median of 3.65)
GF Value™: $0.47 vs. price of $1.52 (223.4% above fair value)
Industry Position: 9.3% above the Medical Distribution median (#50 of 120)
No single metric tells the full story. See the AHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
36GF Score
Get the complete analysis for AHG
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AHG has been successfully added to your 
